{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:22:43Z","timestamp":1784395363386,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jnutbio.2015.12.001","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T03:29:06Z","timestamp":1451878146000},"page":"38-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Metabolic disturbances in plasma as biomarkers for Huntington's disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Mei-Ling","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2015.12.001_bb0005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0015","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/1073858405280639","article-title":"The ubiquitin-proteasome system in Huntington's disease","volume":"11","author":"Valera","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","article-title":"Transcriptional signatures in Huntington's disease","volume":"83","author":"Cha","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0025","first-page":"135","article-title":"Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease","volume":"34","author":"Chen","year":"2011","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/gb-2005-6-3-210","article-title":"Connecting the dots in Huntington's disease with protein interaction networks","volume":"6","author":"Giorgini","year":"2005","journal-title":"Genome Biol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0035","article-title":"Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0050","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibtech.2004.03.007","article-title":"Metabolomics by numbers: acquiring and understanding global metabolite data","volume":"22","author":"Goodacre","year":"2004","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ymgme.2011.11.201","article-title":"ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations","volume":"105","author":"Wuolikainen","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/brain\/awm304","article-title":"Metabolomic profiling to develop blood biomarkers for Parkinson's disease","volume":"131","author":"Bogdanov","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.chroma.2013.06.005","article-title":"A new metabolomic workflow for early detection of Alzheimer's disease","volume":"1302","author":"Ibanez","year":"2013","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0080","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bbadis.2011.08.001","article-title":"(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease","volume":"1812","author":"Verwaest","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0085","first-page":"136","article-title":"Unified Huntington's Disease Rating Scale: reliability and consistency","volume":"11","author":"Group","year":"1996","journal-title":"Huntington Study Group Mov Disord"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0090","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jand.2012.07.035","article-title":"Methodology for adding glycemic index to the national health and nutrition examination survey nutrient database","volume":"112","author":"Lin","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S1734-1140(13)71472-5","article-title":"Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex","volume":"65","author":"Kaminska","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10072-012-0952-x","article-title":"Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington's disease patients","volume":"34","author":"Cuturic","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0110","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/STROKEAHA.111.645994","article-title":"Glycine exerts dual roles in ischemic injury through distinct mechanisms","volume":"43","author":"Yao","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0115","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/exnr.1997.6428","article-title":"Huntington's disease: N-methyl-d-aspartate receptor coagonist glycine is increased in platelets","volume":"144","author":"Reilmann","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0120","series-title":"Biology of the NMDA receptor","article-title":"NMDA receptors and Huntington's disease","author":"Fernandes","year":"2009"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0304-3940(93)90168-K","article-title":"CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC","volume":"154","author":"Nicoli","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2007.07.029","article-title":"Increased metabolism in the R6\/2 mouse model of Huntington's disease","volume":"29","author":"van der Burg","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0135","first-page":"728","article-title":"Is taurine a functional nutrient?","volume":"9","author":"Bouckenooghe","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0140","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00726-011-0962-7","article-title":"Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production","volume":"42","author":"Jong","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0145","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00726-011-0885-3","article-title":"Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-kappaB","volume":"42","author":"Sun","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0150","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00726-010-0751-8","article-title":"Protective functions of taurine against experimental stroke through depressing mitochondria-mediated cell death in rats","volume":"40","author":"Sun","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/1475636031000118428","article-title":"Kinetic studies on the inhibition of GABA-T by gamma-vinyl GABA and taurine","volume":"18","author":"Sulaiman","year":"2003","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0160","series-title":"Metabolism in the nervous system: Springer US","first-page":"501","article-title":"Taurine","author":"Oja","year":"1983"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pbb.2006.02.007","article-title":"Effects of taurine on rat behaviors in three anxiety models","volume":"83","author":"Kong","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0170","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/hmg\/ddt036","article-title":"A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington's disease","volume":"22","author":"Hsiao","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pbb.2005.10.018","article-title":"Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype","volume":"82","author":"Tadros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms","volume":"8","author":"Pla","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1503\/jpn.100067","article-title":"Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography","volume":"36","author":"Krogias","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.40.6.581","article-title":"Biochemical aspects of Huntington's chorea","volume":"40","author":"Caraceni","year":"1977","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0200","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.3390\/ijms141122558","article-title":"Neuroprotective effects of psychotropic drugs in Huntington's disease","volume":"14","author":"Lauterbach","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"Gershon","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2011.05.006","article-title":"Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice","volume":"44","author":"van der Burg","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2013.08.019","article-title":"Neurovascular abnormalities in humans and mice with Huntington's disease","volume":"250","author":"Lin","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0225","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0230","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0005-2760(94)90186-4","article-title":"Phosphatidylcholine breakdown and signal transduction","volume":"1212","author":"Exton","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0235","doi-asserted-by":"crossref","first-page":"14668","DOI":"10.1074\/jbc.271.25.14668","article-title":"A genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells","volume":"271","author":"Cui","year":"1996","journal-title":"J Biol Chem."},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-6-1","article-title":"Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia","volume":"6","author":"Sondag","year":"2009","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0250","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuint.2013.09.007","article-title":"Cytosolic phospholipase A2\u03b1 upregulation mediates apoptotic neuronal death induced by aggregated amyloid-\u03b2 peptide1\u201342","volume":"63","author":"Sagy-Bross","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0255","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2015.12.001_bb0260","first-page":"108","article-title":"Derivatization reagents in liquid chromatography\/electrospray ionization tandem mass spectrometry for biomedical analysis","volume":"1","author":"Santa","year":"2007","journal-title":"Drug Discov Ther"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286315003629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286315003629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:17:10Z","timestamp":1760627830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286315003629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":52,"alternative-id":["S0955286315003629"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2015.12.001","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic disturbances in plasma as biomarkers for Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}